SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer-Reference-Cited by-同舟云学术

SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer

Published:2023-12 Issue:12 Volume:42 Page:113434
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Ohara Yuuki,Tang Wei,Liu Huaitian,Yang Shouhui,Dorsey Tiffany H.,Cawley Helen,Moreno Paloma,Chari Raj,Guest Mary R.,Azizian Azadeh,Gaedcke Jochen,Ghadimi Michael,Hanna Nader,Ambs Stefan,Hussain S. Perwez

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference67 articles.

1. Cancer statistics, 2023;Siegel;CA. Cancer J. Clin.,2023

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA. Cancer J. Clin.,2021

3. Genomic analyses identify molecular subtypes of pancreatic cancer;Bailey;Nature,2016

4. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma;Moffitt;Nat. Genet.,2015

5. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy;Collisson;Nat. Med.,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic ductal adenocarcinoma microenvironment: Soluble factors and cancer associated fibroblasts as modulators of NK cell functions;Immunology Letters;2024-10

2. SerpinB3: A Multifaceted Player in Health and Disease—Review and Future Perspectives;Cancers;2024-07-18

3. ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer;International Journal of Cancer;2024-04-17

4. LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism;Carcinogenesis;2024-02-15

5. SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma;Cancers;2024-01-03